{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T06:28:08Z","timestamp":1794119288847,"version":"4.8.0"},"reference-count":138,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.euroneuro.2024.06.008","type":"journal-article","created":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T09:03:38Z","timestamp":1722243818000},"page":"35-55","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["The effect of antidepressant treatment on blood BDNF levels in depressed patients: A review and methodological recommendations for assessment of BDNF in blood"],"prefix":"10.1016","volume":"87","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3240-0223","authenticated-orcid":false,"given":"Clara A.","family":"Madsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam L.","family":"Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6939-5088","authenticated-orcid":false,"given":"Betina","family":"Elfving","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9377-9436","authenticated-orcid":false,"given":"Lars V.","family":"Kessing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eero","family":"Castr\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens D.","family":"Mikkelsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1508-6866","authenticated-orcid":false,"given":"Gitte M.","family":"Knudsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2024.06.008_bib0001","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jad.2015.06.033","article-title":"2015. Serum BDNF as a peripheral biomarker of treatment-resistant depression and the rapid antidepressant response: a comparison of ketamine and ECT","volume":"186","author":"Allen","year":"2015","journal-title":"J. Affect Disord"},{"key":"10.1016\/j.euroneuro.2024.06.008_bib0002","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyg.2019.01234","article-title":"Modulation of Serum Brain-Derived Neurotrophic Factor by a Single Dose of Ayahuasca: Observation From a Randomized Controlled Trial","volume":"10","author":"de Almeida","year":"2019","journal-title":"Front Psychol"},{"issue":"9","key":"10.1016\/j.euroneuro.2024.06.008_bib0003","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18091987","article-title":"Effect of clotting duration and temperature on BDNF measurement in human serum","volume":"18","author":"Amadio","year":"2017","journal-title":"Int. J. Mol. Sci"},{"key":"10.1016\/j.euroneuro.2024.06.008_bib0004","doi-asserted-by":"crossref","DOI":"10.3389\/fnbeh.2021.626906","article-title":"Blood brain-derived neurotrophic factor (BDNF) and major depression: do we have a translational perspective?","volume":"15","author":"Arosio","year":"2021","journal-title":"Front. Behav. Neurosci"},{"issue":"4","key":"10.1016\/j.euroneuro.2024.06.008_bib0005","doi-asserted-by":"crossref","DOI":"10.1097\/JCP.0b013e3181abdfd7","article-title":"Mean Platelet Volume in Patients With Major Depression: Effect of Escitalopram Treatment","volume":"29","author":"Ataoglu","year":"2009","journal-title":"J Clin Psychopharmacol"},{"issue":"2","key":"10.1016\/j.euroneuro.2024.06.008_bib0006","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1124\/pr.111.005108","article-title":"Brain-derived neurotrophic factor and neuropsychiatric disorders","volume":"64","author":"Autry","year":"2012","journal-title":"Pharmacol. Rev"},{"issue":"8","key":"10.1016\/j.euroneuro.2024.06.008_bib0007","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1097\/NMD.0000000000000574","article-title":"The comparison of effectiveness of various potential predictors of response to treatment with SSRIS in patients with depressive disorder","volume":"205","author":"Bares","year":"2017","journal-title":"J. Nerv. Ment. Dis"},{"issue":"2","key":"10.1016\/j.euroneuro.2024.06.008_bib0008","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.pnpbp.2008.11.016","article-title":"Effects of fluoxetine and venlafaxine on serum brain derived neurotrophic factor levels in depressed patients","volume":"33","author":"Ba\u015fterzi","year":"2009","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"6","key":"10.1016\/j.euroneuro.2024.06.008_bib0009","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.5114\/aoms.2015.56342","article-title":"Brain-derived neurotrophic factor and its clinical implications","volume":"11","author":"Bathina","year":"2015","journal-title":"Arch. Med. Sci"},{"issue":"4","key":"10.1016\/j.euroneuro.2024.06.008_bib0010","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1002\/cpt.2487","article-title":"Acute effects of psilocybin after escitalopram or placebo pretreatment in a randomized, double-blind, placebo-controlled, crossover study in healthy subjects","volume":"111","author":"Becker","year":"2021","journal-title":"Clin. Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.euroneuro.2024.06.008_bib0011","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1093\/humrep\/del479","article-title":"Influence of endogenous and exogenous sex hormones on plasma brain-derived neurotrophic factor","volume":"22","author":"Begliuomini","year":"2007","journal-title":"Hum. Reprod"},{"issue":"2","key":"10.1016\/j.euroneuro.2024.06.008_bib0012","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1677\/JOE-07-0376","article-title":"Plasma brain-derived neurotrophic factor daily variations in men: correlation with cortisol circadian rhythm","volume":"197","author":"Begliuomini","year":"2008","journal-title":"J. Endocrinol"},{"issue":"4","key":"10.1016\/j.euroneuro.2024.06.008_bib0013","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","article-title":"Antidepressant effects of ketamine in depressed patients","volume":"47","author":"Berman","year":"2000","journal-title":"Biol. Psychiatry"},{"issue":"8","key":"10.1016\/j.euroneuro.2024.06.008_bib0014","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/mp.2008.119","article-title":"The mood-improving actions of antidepressants do not depend on neurogenesis but are associated with neuronal remodeling","volume":"14","author":"Bessa","year":"2009","journal-title":"Mol. Psychiatry"},{"issue":"1\u20132","key":"10.1016\/j.euroneuro.2024.06.008_bib0015","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jad.2011.08.013","article-title":"Decreased serotonin content and reduced agonist-induced aggregation in platelets of patients chronically medicated with SSRI drugs","volume":"136","author":"Bismuth-Evenzal","year":"2012","journal-title":"J. Affect Disord"},{"key":"10.1016\/j.euroneuro.2024.06.008_bib0016","article-title":"Platelets selectively regulate the release of BDNF","volume":"11","author":"Le Blanc","year":"2020","journal-title":"proBDNF. Front. Immunol."},{"issue":"6","key":"10.1016\/j.euroneuro.2024.06.008_bib0136","doi-asserted-by":"crossref","first-page":"763","DOI":"10.3109\/15622971003611319","article-title":"Serum and plasma BDNF levels in major depression: a replication study and meta-analyses","volume":"11","author":"Bocchio-Chiavetto","year":"2010","journal-title":"World J Biol Psychiatry"},{"issue":"8","key":"10.1016\/j.euroneuro.2024.06.008_bib0017","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.euroneuro.2006.04.010","article-title":"Electroconvulsive therapy (ECT) increases serum brain derived neurotrophic factor (BDNF) in drug resistant depressed patients","volume":"16","author":"Bocchio-Chiavetto","year":"2006","journal-title":"Eur. Neuropsychopharmacol"},{"issue":"11","key":"10.1016\/j.euroneuro.2024.06.008_bib0018","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1038\/npp.2016.86","article-title":"Relationship between hippocampal volume, serum BDNF, and depression severity following electroconvulsive therapy in late-life depression","volume":"41","author":"Bouckaert","year":"2016","journal-title":"Neuropsychopharmacology"},{"issue":"8","key":"10.1016\/j.euroneuro.2024.06.008_bib0019","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1017\/S1461145708009309","article-title":"A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression","volume":"11","author":"Brunoni","year":"2008","journal-title":"Int. J. Neuropsychopharmacol"},{"issue":"3","key":"10.1016\/j.euroneuro.2024.06.008_bib0020","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00406-014-0543-3","article-title":"Focus on ECT seizure quality: serum BDNF as a peripheral biomarker in depressed patients","volume":"265","author":"Bumb","year":"2014","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci"},{"issue":"2","key":"10.1016\/j.euroneuro.2024.06.008_bib0021","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.psyneuen.2010.07.013","article-title":"Determinants of serum brain-derived neurotrophic factor","volume":"36","author":"Bus","year":"2011","journal-title":"Psychoneuroendocrinology"},{"issue":"4","key":"10.1016\/j.euroneuro.2024.06.008_bib0022","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/ANA.0000000000000511","article-title":"Ketamine anesthesia does not improve depression scores in electroconvulsive therapy: a randomized clinical trial","volume":"30","author":"Carspecken","year":"2018","journal-title":"J. Neurosurg. Anesthesiol"},{"key":"10.1016\/j.euroneuro.2024.06.008_bib0023","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cell.2021.01.034","article-title":"Antidepressant drugs act by directly binding to TRKB neurotrophin receptors","volume":"184","author":"Casarotto","year":"2021","journal-title":"Cell"},{"issue":"19","key":"10.1016\/j.euroneuro.2024.06.008_bib0024","doi-asserted-by":"crossref","first-page":"9872","DOI":"10.1074\/jbc.M116.720029","article-title":"Brain-derived Neurotrophic Factor in Megakaryocytes","volume":"291","author":"Chac\u00f3n-Fern\u00e1ndez","year":"2016","journal-title":"J. Biol. Chem"},{"issue":"4","key":"10.1016\/j.euroneuro.2024.06.008_bib0025","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S0006-3223(01)01083-6","article-title":"Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication","volume":"50","author":"Chen","year":"2001","journal-title":"Biol. Psychiatry"},{"issue":"11","key":"10.1016\/j.euroneuro.2024.06.008_bib0026","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/sj.mp.4002059","article-title":"Reduced overflow of BDNF from the brain is linked with suicide risk in depressive illness","volume":"12","author":"Dawood","year":"2007","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2024.06.008_bib0027","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.neuropharm.2013.04.054","article-title":"Shaping neurons: long and short range effects of mature and proBDNF signalling upon neuronal structure","volume":"76","author":"Deinhardt","year":"2014","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.euroneuro.2024.06.008_bib0028","first-page":"54","article-title":"Changes of serum concentrations of brain-derived neurotrophic factor (BDNF) during treatment with venlafaxine and mirtazapine: role of medication and response to treatment","volume":"46","author":"Deuschle","year":"2013","journal-title":"Pharmacopsychiatry"},{"issue":"3","key":"10.1016\/j.euroneuro.2024.06.008_bib0029","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/nm.4050","article-title":"Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants","volume":"22","author":"Duman","year":"2016","journal-title":"Nat. Med"},{"issue":"7","key":"10.1016\/j.euroneuro.2024.06.008_bib0030","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1001\/archpsyc.1997.01830190015002","article-title":"A molecular and cellular theory of depression","volume":"54","author":"Duman","year":"1997","journal-title":"Arch. Gen. Psychiatry"},{"issue":"2","key":"10.1016\/j.euroneuro.2024.06.008_bib0031","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1017\/S1461145712000545","article-title":"Concomitant BDNF and sleep slow wave changes indicate ketamine-induced plasticity in major depressive disorder","volume":"16","author":"Duncan","year":"2013","journal-title":"Int. J. Neuropsychopharmacol"},{"issue":"8","key":"10.1016\/j.euroneuro.2024.06.008_bib0032","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1001\/archpsyc.60.8.804","article-title":"Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects","volume":"60","author":"Dwivedi","year":"2003","journal-title":"Arch. Gen. Psychiatry"},{"issue":"9","key":"10.1016\/j.euroneuro.2024.06.008_bib0033","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.jpsychires.2012.05.003","article-title":"Depression, the Val66Met polymorphism, age, and gender influence the serum BDNF level","volume":"46","author":"Elfving","year":"2012","journal-title":"J. Psychiatr. Res"},{"issue":"1","key":"10.1016\/j.euroneuro.2024.06.008_bib0034","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jneumeth.2009.12.017","article-title":"Detection of brain-derived neurotrophic factor (BDNF) in rat blood and brain preparations using ELISA: pitfalls and solutions","volume":"187","author":"Elfving","year":"2010","journal-title":"J. Neurosci. Methods"},{"issue":"15","key":"10.1016\/j.euroneuro.2024.06.008_bib0035","doi-asserted-by":"crossref","first-page":"5368","DOI":"10.1523\/JNEUROSCI.6251-09.2010","article-title":"Brain-derived neurotrophic factor is associated with age-related decline in hippocampal volume","volume":"30","author":"Erickson","year":"2010","journal-title":"J. Neurosci"},{"issue":"3","key":"10.1016\/j.euroneuro.2024.06.008_bib0036","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.neulet.2009.02.032","article-title":"Serum brain-derived neurotrophic factor (BDNF) is not associated with response to electroconvulsive therapy (ECT): a pilot study in drug resistant depressed patients","volume":"453","author":"Fernandes","year":"2009","journal-title":"Neurosci. Lett"},{"issue":"4","key":"10.1016\/j.euroneuro.2024.06.008_bib0037","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1055\/s-0037-1613072","article-title":"Brain-derived neurotrophic factor is stored in human platelets and released by agonist stimulation","volume":"87","author":"Fujimura","year":"2002","journal-title":"Thromb. Haemost"},{"issue":"1","key":"10.1016\/j.euroneuro.2024.06.008_bib0038","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1461145709991039","article-title":"Peripheral brain-derived neurotrophic factor (BDNF) as a biomarker for affective disorders?","volume":"13","author":"Gass","year":"2010","journal-title":"Int. J. Neuropsychopharmacol"},{"issue":"1","key":"10.1016\/j.euroneuro.2024.06.008_bib0039","doi-asserted-by":"crossref","first-page":"9655","DOI":"10.1038\/s41598-019-45976-5","article-title":"Associations between serum and plasma brain-derived neurotrophic factor and influence of storage time and centrifugation strategy","volume":"9","author":"Gejl","year":"2019","journal-title":"Sci. Rep"},{"issue":"18","key":"10.1016\/j.euroneuro.2024.06.008_bib0040","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1056\/NEJMoa2206443","article-title":"Single-dose psilocybin for a treatment-resistant episode of major depression","volume":"387","author":"Goodwin","year":"2022","journal-title":"N. Engl. J. Med"},{"issue":"7","key":"10.1016\/j.euroneuro.2024.06.008_bib0041","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jpsychires.2013.03.006","article-title":"Additional ECT increases BDNF-levels in patients suffering from major depressive disorders compared to patients treated with citalopram only","volume":"47","author":"Haghighi","year":"2013","journal-title":"J. Psychiatr. Res"},{"issue":"2","key":"10.1016\/j.euroneuro.2024.06.008_bib0042","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1017\/S1461145713001119","article-title":"Plasma brain derived neurotrophic factor (BDNF) and response to ketamine in treatment-resistant depression","volume":"17","author":"Haile","year":"2014","journal-title":"Int. J. Neuropsychopharmacol"},{"issue":"2","key":"10.1016\/j.euroneuro.2024.06.008_bib0043","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1055\/s-2007-1004594","article-title":"Serum concentrations of nerve growth factor and brain-derived neurotrophic factor in depressed patients before and after antidepressant treatment","volume":"41","author":"Hellweg","year":"2008","journal-title":"Pharmacopsychiatry"},{"issue":"2","key":"10.1016\/j.euroneuro.2024.06.008_bib0044","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/ajmg.b.32616","article-title":"A comprehensive review of genetic and epigenetic mechanisms that regulate BDNF expression and function with relevance to major depressive disorder","volume":"177","author":"Hing","year":"2018","journal-title":"Am. J. Med. Genet. Part. B. Neuropsychiatr. Genet"},{"issue":"Suppl 6","key":"10.1016\/j.euroneuro.2024.06.008_bib0045","first-page":"4","article-title":"History and evolution of the monoamine hypothesis of depression","volume":"61","author":"Hirschfeld","year":"2000","journal-title":"J. Clin. Psychiatry"},{"issue":"4","key":"10.1016\/j.euroneuro.2024.06.008_bib0046","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1038\/s41380-022-01465-2","article-title":"Imaging the effect of ketamine on synaptic density (SV2A) in the living brain","volume":"27","author":"Holmes","year":"2022","journal-title":"Mol. Psychiatry"},{"issue":"5","key":"10.1016\/j.euroneuro.2024.06.008_bib0047","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0893-133X(00)00159-7","article-title":"The corticosteroid receptor hypothesis of depression","volume":"23","author":"Holsboer","year":"2000","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.euroneuro.2024.06.008_bib0048","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/s41386-020-00883-6","article-title":"Acute dose-dependent effects of lysergic acid diethylamide in a double-blind placebo-controlled study in healthy subjects","volume":"46","author":"Holze","year":"2021","journal-title":"Neuropsychopharmacology"},{"issue":"13","key":"10.1016\/j.euroneuro.2024.06.008_bib0049","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23136919","article-title":"Chronic SSRI treatment, but not norepinephrine reuptake inhibitor treatment, increases neurogenesis in juvenile rats","volume":"23","author":"Hovorka","year":"2022","journal-title":"Int. J. Mol. Sci"},{"issue":"2","key":"10.1016\/j.euroneuro.2024.06.008_bib0050","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/YCT.0b013e3181c18bbf","article-title":"The level of serum brain-derived neurotrophic factor is associated with the therapeutic efficacy of modified electroconvulsive therapy in chinese patients with depression","volume":"26","author":"Hu","year":"2010","journal-title":"J. ECT"},{"issue":"2","key":"10.1016\/j.euroneuro.2024.06.008_bib0051","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1021\/acsptsci.0c00099","article-title":"Low doses of LSD acutely increase BDNF blood plasma levels in healthy volunteers","volume":"4","author":"Hutten","year":"2021","journal-title":"ACS. Pharmacol. Transl. Sci"},{"issue":"10","key":"10.1016\/j.euroneuro.2024.06.008_bib0052","doi-asserted-by":"crossref","first-page":"4272","DOI":"10.1038\/s41380-023-02285-8","article-title":"Effects of escitalopram on synaptic density in the healthy human brain: a randomized controlled trial","volume":"28","author":"Johansen","year":"2023","journal-title":"Mol. Psychiatry"},{"issue":"9","key":"10.1016\/j.euroneuro.2024.06.008_bib0053","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.biopsych.2005.01.008","article-title":"Low Brain-Derived Neurotrophic Factor (BDNF) levels in serum of depressed patients probably results from lowered platelet BDNF release unrelated to platelet reactivity","volume":"57","author":"Karege","year":"2005","journal-title":"Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.euroneuro.2024.06.008_bib0054","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0304-3940(02)00529-3","article-title":"Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets","volume":"328","author":"Karege","year":"2002","journal-title":"Neurosci. Lett"},{"issue":"1\u20132","key":"10.1016\/j.euroneuro.2024.06.008_bib0055","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.molbrainres.2004.12.020","article-title":"Neurotrophin levels in postmortem brains of suicide victims and the effects of antemortem diagnosis and psychotropic drugs","volume":"136","author":"Karege","year":"2005","journal-title":"Mol. Brain Res"},{"issue":"10053","key":"10.1016\/j.euroneuro.2024.06.008_bib0056","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/S0140-6736(16)31460-X","article-title":"Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990\u20132015: a systematic analysis for the global burden of disease study 2015","volume":"388","author":"Kassebaum","year":"2016","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.euroneuro.2024.06.008_bib0057","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.ijdevneu.2007.07.002","article-title":"Age-related changes in BDNF protein levels in human serum: differences between autism cases and normal controls","volume":"25","author":"Katoh-Semba","year":"2007","journal-title":"Int. J. Dev. Neurosci"},{"issue":"6","key":"10.1016\/j.euroneuro.2024.06.008_bib0058","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s00702-014-1336-6","article-title":"BDNF serum levels and promoter methylation of BDNF exon I, IV and VI in depressed patients receiving electroconvulsive therapy","volume":"122","author":"Kleimann","year":"2014","journal-title":"J. Neural Transm"},{"issue":"3","key":"10.1016\/j.euroneuro.2024.06.008_bib0059","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1017\/S1461145710000738","article-title":"Blood BDNF concentrations reflect brain-tissue BDNF levels across species","volume":"14","author":"Klein","year":"2011","journal-title":"Int. J. Neuropsychopharmacol"},{"issue":"3","key":"10.1016\/j.euroneuro.2024.06.008_bib0060","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1159\/000209350","article-title":"Changes in CREB phosphorylation and BDNF plasma levels during psychotherapy of depression","volume":"78","author":"Koch","year":"2009","journal-title":"Psychother. Psychosom"},{"key":"10.1016\/j.euroneuro.2024.06.008_bib0061","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.pscychresns.2018.08.013","article-title":"Increases in orbitofrontal cortex thickness following antidepressant treatment are associated with changes in resting state autonomic function in adolescents with major depression \u2013 preliminary findings from a pilot study","volume":"281","author":"Koenig","year":"2018","journal-title":"Psych. Res. Neuroimag."},{"key":"10.1016\/j.euroneuro.2024.06.008_bib0062","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2023.115283","article-title":"Exercise elevates serum brain-derived neurotrophic factor in partially remitted depression","volume":"326","author":"Kramer","year":"2023","journal-title":"Psychiatry Res"},{"issue":"April","key":"10.1016\/j.euroneuro.2024.06.008_bib0063","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.neulet.2019.04.023","article-title":"Association between the novel seizure quality index for the outcome prediction in electroconvulsive therapy and brain-derived neurotrophic factor serum levels","volume":"704","author":"Kranaster","year":"2019","journal-title":"Neurosci. Lett"},{"key":"10.1016\/j.euroneuro.2024.06.008_bib0064","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.neubiorev.2017.03.007","article-title":"Serotonin and neuroplasticity \u2013 links between molecular, functional and structural pathophysiology in depression","volume":"77","author":"Kraus","year":"2017","journal-title":"Neurosci. Biobehav. Rev"},{"key":"10.1016\/j.euroneuro.2024.06.008_bib0065","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.neurobiolaging.2021.01.020","article-title":"BDNF serum concentrations in 2053 participants of the Berlin aging study II","volume":"101","author":"Kronenberg","year":"2021","journal-title":"Neurobiol. Aging"},{"issue":"5","key":"10.1016\/j.euroneuro.2024.06.008_bib0066","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.biopsych.2007.01.002","article-title":"Correlation between serum brain-derived neurotrophic factor level and an in vivo marker of cortical integrity","volume":"62","author":"Lang","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2024.06.008_bib0067","first-page":"1","article-title":"Effects of electroconvulsive therapy on depression and its potential mechanism","volume":"11","author":"Li","year":"2020","journal-title":"Front. Psychol"},{"issue":"2","key":"10.1016\/j.euroneuro.2024.06.008_bib0068","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1159\/000352013","article-title":"Electroconvulsive therapy improves clinical manifestation with plasma BDNF levels unchanged in treatment-resistant depression patients","volume":"68","author":"Lin","year":"2013","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.euroneuro.2024.06.008_bib0069","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3389\/fnbeh.2014.00143","article-title":"Mice with altered BDNF signaling as models for mood disorders and antidepressant effects","volume":"8","author":"Lindholm","year":"2014","journal-title":"Front. Behav. Neurosci"},{"key":"10.1016\/j.euroneuro.2024.06.008_bib0070","first-page":"1","article-title":"From serotonin to neuroplasticity: evolvement of theories for major depressive disorder. Front","volume":"11","author":"Liu","year":"2017","journal-title":"Cell Neurosci"},{"key":"10.1016\/j.euroneuro.2024.06.008_bib0071","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jpsychires.2019.08.002","article-title":"Changes in the global burden of depression from 1990 to 2017: findings from the Global Burden of Disease study","volume":"126","author":"Liu","year":"2020","journal-title":"J. Psychiatr. Res"},{"issue":"1","key":"10.1016\/j.euroneuro.2024.06.008_bib0072","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.neurobiolaging.2004.03.002","article-title":"The impact of age, weight and gender on BDNF levels in human platelets and plasma","volume":"26","author":"Lommatzsch","year":"2005","journal-title":"Neurobiol. Aging"},{"issue":"3","key":"10.1016\/j.euroneuro.2024.06.008_bib0073","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/YCT.0000000000000583","article-title":"BDNF genotype and baseline serum levels in relation to electroconvulsive therapy effectiveness in treatment-resistant depressed patients","volume":"35","author":"Maffioletti","year":"2019","journal-title":"J. ECT"},{"issue":"3","key":"10.1016\/j.euroneuro.2024.06.008_bib0074","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2144\/000114204","article-title":"Influence of clotting duration on brain-derived neurotrophic factor (BDNF) dosage in serum","volume":"57","author":"Maffioletti","year":"2018","journal-title":"BioTechniques"},{"key":"10.1016\/j.euroneuro.2024.06.008_bib0075","doi-asserted-by":"crossref","first-page":"l7069","DOI":"10.1136\/bmj.l7069","article-title":"Esketamine is approved in Europe for treating resistant major depressive disorder","volume":"367","author":"Mahase","year":"2019","journal-title":"BMJ"},{"issue":"24","key":"10.1016\/j.euroneuro.2024.06.008_bib0076","doi-asserted-by":"crossref","first-page":"9104","DOI":"10.1523\/JNEUROSCI.20-24-09104.2000","article-title":"Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus","volume":"20","author":"Malberg","year":"2000","journal-title":"J. Neurosci"},{"issue":"4","key":"10.1016\/j.euroneuro.2024.06.008_bib0077","doi-asserted-by":"crossref","first-page":"512","DOI":"10.4088\/JCP.v68n0404","article-title":"Increased plasma concentration of brain-derived neurotrophic factor with electroconvulsive therapy: a pilot study in patients with major depression","volume":"68","author":"Marano","year":"2007","journal-title":"J. Clin. Psychiatry"},{"issue":"1","key":"10.1016\/j.euroneuro.2024.06.008_bib0078","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/sj.npp.1301571","article-title":"Interaction between BDNF and serotonin: role in mood disorders","volume":"33","author":"Martinowich","year":"2008","journal-title":"Neuropsychopharmacology"},{"issue":"5874","key":"10.1016\/j.euroneuro.2024.06.008_bib0079","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1126\/science.1150516","article-title":"The antidepressant fluoxetine restores plasticity in the adult visual cortex","volume":"320","author":"Maya Vetencourt","year":"2008","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.euroneuro.2024.06.008_bib0080","first-page":"41","article-title":"A meta-analysis examining clinical predictors of hippocampal volume in patients with major depressive disorder","volume":"34","author":"McKinnon","year":"2009","journal-title":"J. Psychiatry Neurosci"},{"key":"10.1016\/j.euroneuro.2024.06.008_bib0081","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.psyneuen.2014.02.001","article-title":"2014. BDNF in late-life depression: effect of SSRI usage and interaction with childhood abuse","volume":"43","author":"Van der Meij","year":"2014","journal-title":"Psychoneuroendocrinology"},{"issue":"4","key":"10.1016\/j.euroneuro.2024.06.008_bib0082","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1124\/mi.10.4.6","article-title":"Molecular mechanisms of SERT in platelets: regulation of plasma serotonin levels","volume":"10","author":"Mercado","year":"2010","journal-title":"Mol. Interv"},{"key":"10.1016\/j.euroneuro.2024.06.008_bib0083","article-title":"Brain-derived neurotrophic factor: a key molecule for memory in the healthy and the pathological brain. Front","volume":"13","author":"Miranda","year":"2019","journal-title":"Cell Neurosci"},{"issue":"11","key":"10.1016\/j.euroneuro.2024.06.008_bib0138","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0048046","article-title":"Serum BDNF Concentrations Show Strong Seasonal Variation and Correlations with the Amount of Ambient Sunlight","volume":"7","author":"Molendijk","year":"2012","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.euroneuro.2024.06.008_bib0084","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/s41593-023-01316-5","article-title":"Psychedelics promote plasticity by directly binding to BDNF receptor TrkB","volume":"26","author":"Moliner","year":"2023","journal-title":"Nat. Neurosci"},{"issue":"4","key":"10.1016\/j.euroneuro.2024.06.008_bib0085","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/j.1538-7836.2009.03278.x","article-title":"The association of depression with platelet activation: evidence for a treatment effect","volume":"7","author":"Morel-Kopp","year":"2009","journal-title":"J. Thromb. Haemost"},{"issue":"2","key":"10.1016\/j.euroneuro.2024.06.008_bib0086","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0014-5793(00)01302-8","article-title":"Vascular endothelial cells synthesize and secrete brain-derived neurotrophic factor","volume":"470","author":"Nakahashi","year":"2000","journal-title":"FEBS. Lett"},{"issue":"1","key":"10.1016\/j.euroneuro.2024.06.008_bib0087","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0896-6273(02)00653-0","article-title":"Neurobiology of depression","volume":"34","author":"Nestler","year":"2002","journal-title":"Neuron"},{"issue":"11","key":"10.1016\/j.euroneuro.2024.06.008_bib0088","doi-asserted-by":"crossref","first-page":"3650","DOI":"10.3390\/ijms19113650","article-title":"Actions of brain-derived neurotrophin factor in the neurogenesis and neuronal function, and its involvement in the pathophysiology of brain diseases","volume":"19","author":"Numakawa","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.euroneuro.2024.06.008_bib0089","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.pnpbp.2008.02.009","article-title":"Efficacy of electroconvulsive therapy is associated with changing blood levels of homovanillic acid and brain-derived neurotrophic factor (BDNF) in refractory depressed patients: a pilot study","volume":"32","author":"Okamoto","year":"2008","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2024.06.008_bib0090","first-page":"1","article-title":"Major depressive disorder","volume":"2","author":"Otte","year":"2016","journal-title":"Nat. Rev. Dis. Prim"},{"issue":"1","key":"10.1016\/j.euroneuro.2024.06.008_bib0091","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/00124509-200403000-00004","article-title":"Efficacy of ECT in depression: a meta-analytic review","volume":"20","author":"Pagnin","year":"2004","journal-title":"J. ECT"},{"issue":"12","key":"10.1016\/j.euroneuro.2024.06.008_bib0092","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/S0028-3908(98)00141-5","article-title":"Transport of brain-derived neurotrophic factor across the blood\u2013brain barrier","volume":"37","author":"Pan","year":"1998","journal-title":"Neuropharmacology"},{"issue":"8","key":"10.1016\/j.euroneuro.2024.06.008_bib0093","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1017\/S1461145708009000","article-title":"Brain-derived neurotrophic factor and tyrosine kinase B receptor signalling in post-mortem brain of teenage suicide victims","volume":"11","author":"Pandey","year":"2008","journal-title":"Int. J. Neuropsychopharmacol"},{"issue":"5","key":"10.1016\/j.euroneuro.2024.06.008_bib0094","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1023\/A:1018940732550","article-title":"Transport of human recombinant brain-derived neurotrophic factor (bdnf) through the rat blood\u2212brain barrier in vivo using vector-mediated peptide drug delivery","volume":"11","author":"Pardridge","year":"1994","journal-title":"Pharm. Res"},{"issue":"1","key":"10.1016\/j.euroneuro.2024.06.008_bib0095","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/nrn3379","article-title":"Neurotrophin regulation of neural circuit development and function","volume":"14","author":"Park","year":"2013","journal-title":"Nat. Rev. Neurosci"},{"issue":"5","key":"10.1016\/j.euroneuro.2024.06.008_bib0096","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.euroneuro.2009.01.002","article-title":"Plasma Brain-Derived Neurotrophic Factor in treatment-resistant depressed patients receiving electroconvulsive therapy","volume":"19","author":"Piccinni","year":"2009","journal-title":"Eur. Neuropsychopharmacol"},{"issue":"1\u20133","key":"10.1016\/j.euroneuro.2024.06.008_bib0097","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jad.2007.05.005","article-title":"Plasma and serum brain-derived neurotrophic factor (BDNF) in depressed patients during 1 year of antidepressant treatments","volume":"105","author":"Piccinni","year":"2008","journal-title":"J. Affect Disord"},{"issue":"2","key":"10.1016\/j.euroneuro.2024.06.008_bib0098","first-page":"280","article-title":"Permeability at the blood-brain and blood-nerve barriers of the neurotrophic factors: NGF, CNTF, NT-3, BDNF. Mol","volume":"36","author":"Poduslo","year":"1996","journal-title":"Brain Res"},{"issue":"1","key":"10.1016\/j.euroneuro.2024.06.008_bib0099","doi-asserted-by":"crossref","first-page":"17989","DOI":"10.1038\/srep17989","article-title":"A method for reproducible measurements of serum BDNF: comparison of the performance of six commercial assays","volume":"5","author":"Polacchini","year":"2015","journal-title":"Sci. Rep"},{"issue":"2015","key":"10.1016\/j.euroneuro.2024.06.008_bib0100","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.jad.2014.11.044","article-title":"BDNF as a biomarker for successful treatment of mood disorders: a systematic & quantitative meta-analysis","volume":"174","author":"Polyakova","year":"2015","journal-title":"J. Affect Disord"},{"issue":"9","key":"10.1016\/j.euroneuro.2024.06.008_bib0101","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1001\/jama.2023.14530","article-title":"Single-dose psilocybin treatment for major depressive disorder: a randomized clinical trial","volume":"330","author":"Raison","year":"2023","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.euroneuro.2024.06.008_bib0102","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1159\/000507371","article-title":"Association of serum biomarker levels and BDNF gene polymorphism with response to selective serotonin reuptake inhibitors in indian patients with major depressive disorder","volume":"80","author":"Ramesh","year":"2021","journal-title":"Neuropsychobiology"},{"issue":"2\u20133","key":"10.1016\/j.euroneuro.2024.06.008_bib0103","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.psychres.2015.04.009","article-title":"Electroconvulsive therapy improves clinical manifestations of treatment-resistant depression without changing serum BDNF levels","volume":"227","author":"Rapinesi","year":"2015","journal-title":"Psychiatry Res"},{"issue":"10","key":"10.1016\/j.euroneuro.2024.06.008_bib0104","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1113\/expphysiol.2009.048512","article-title":"Evidence for a release of brain-derived neurotrophic factor from the brain during exercise","volume":"94","author":"Rasmussen","year":"2009","journal-title":"Exp. Physiol"},{"issue":"7","key":"10.1016\/j.euroneuro.2024.06.008_bib0105","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.cpr.2011.07.004","article-title":"Prevalence and clinical course of depression: a review","volume":"31","author":"Richards","year":"2011","journal-title":"Clin. Psychol. Rev"},{"issue":"11","key":"10.1016\/j.euroneuro.2024.06.008_bib0106","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1176\/ajp.2006.163.11.1905","article-title":"Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report","volume":"163","author":"Rush","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2024.06.008_bib0107","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jpsychires.2016.01.012","article-title":"2016. Electroconvulsive therapy (ECT) and aerobic exercise training (AET) increased plasma BDNF and ameliorated depressive symptoms in patients suffering from major depressive disorder","volume":"76","author":"Salehi","year":"2016","journal-title":"J. Psychiatr. Res"},{"issue":"4","key":"10.1016\/j.euroneuro.2024.06.008_bib0108","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1590\/2237-6089-2017-0130","article-title":"Global hippocampal atrophy in major depressive disorder: a meta-analysis of magnetic resonance imaging studies","volume":"40","author":"Santos","year":"2018","journal-title":"Trends Psychiatry Psychother"},{"issue":"6","key":"10.1016\/j.euroneuro.2024.06.008_bib0109","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1055\/s-0029-1224162","article-title":"Correlations and discrepancies between serum and brain tissue levels of neurotrophins after electroconvulsive treatment in rats","volume":"42","author":"Sartorius","year":"2009","journal-title":"Pharmacopsychiatry"},{"issue":"1","key":"10.1016\/j.euroneuro.2024.06.008_bib0110","doi-asserted-by":"crossref","first-page":"84","DOI":"10.5498\/wjp.v6.i1.84","article-title":"Are the changes in the peripheral brain-derived neurotrophic factor levels due to platelet activation?","volume":"6","author":"Serra-Mill\u00e0s","year":"2016","journal-title":"World J. Psychiatry"},{"issue":"1","key":"10.1016\/j.euroneuro.2024.06.008_bib0111","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00213-011-2180-0","article-title":"Changes in plasma and platelet BDNF levels induced by S-citalopram in major depression","volume":"216","author":"Serra-Mill\u00e0s","year":"2011","journal-title":"Psychopharmacol. (Berl)"},{"key":"10.1016\/j.euroneuro.2024.06.008_bib0112","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.eurpsy.2017.06.009","article-title":"Brain-derived neurotrophic factor (BDNF) and neurotrophin 3 (NT3) levels in post-mortem brain tissue from patients with depression compared to healthy individuals \u2013 a proof of concept study","volume":"46","author":"Sheldrick","year":"2017","journal-title":"Eur. Psychiatry"},{"issue":"87","key":"10.1016\/j.euroneuro.2024.06.008_bib0113","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.euroneuro.2020.09.633","article-title":"Value of peripheral neurotrophin levels for the diagnosis of depression and response to treatment: a systematic review and meta-analysis","volume":"41","author":"Shi","year":"2020","journal-title":"Eur. Neuropsychopharmacol"},{"issue":"5","key":"10.1016\/j.euroneuro.2024.06.008_bib0114","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1440-1819.2012.02355.x","article-title":"Platelet count alterations associated with escitalopram, venlafaxine and bupropion in depressive patients","volume":"66","author":"Song","year":"2012","journal-title":"Psychiatry Clin. Neurosci"},{"key":"10.1016\/j.euroneuro.2024.06.008_bib0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.nicl.2020.102178","article-title":"An investigation of cortical thickness and antidepressant response in major depressive disorder: a CAN-BIND study report","volume":"25","author":"Suh","year":"2020","journal-title":"NeuroImage Clin"},{"issue":"5","key":"10.1016\/j.euroneuro.2024.06.008_bib0116","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1016\/j.thromres.2011.06.002","article-title":"Release reaction of brain-derived neurotrophic factor (BDNF) through PAR1 activation and its two distinct pools in human platelets","volume":"128","author":"Tamura","year":"2011","journal-title":"Thromb. Res"},{"issue":"8","key":"10.1016\/j.euroneuro.2024.06.008_bib0137","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1097\/PSY.0b013e3182306a4f","article-title":"Neuroticism, depressive symptoms, and serum BDNF","volume":"73","author":"Terracciano","year":"2011","journal-title":"Psychosom Med"},{"issue":"1\u20133","key":"10.1016\/j.euroneuro.2024.06.008_bib0117","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.brainresbull.2007.03.009","article-title":"Measurements of brain-derived neurotrophic factor: methodological aspects and demographical data","volume":"73","author":"Trajkovska","year":"2007","journal-title":"Brain Res. Bull"},{"issue":"1","key":"10.1016\/j.euroneuro.2024.06.008_bib0118","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1176\/appi.ajp.163.1.28","article-title":"Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice","volume":"163","author":"Trivedi","year":"2006","journal-title":"Am. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.euroneuro.2024.06.008_bib0119","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1159\/000358061","article-title":"Preanalysis storage conditions influence the measurement of brain-derived neurotrophic factor levels in peripheral blood","volume":"69","author":"Tsuchimine","year":"2014","journal-title":"Neuropsychobiology"},{"issue":"4","key":"10.1016\/j.euroneuro.2024.06.008_bib0120","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.brs.2019.02.015","article-title":"Acute and subsequent continuation electroconvulsive therapy elevates serum BDNF levels in patients with major depression","volume":"12","author":"Vanicek","year":"2019","journal-title":"Brain Stimul"},{"issue":"5","key":"10.1016\/j.euroneuro.2024.06.008_bib0121","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/acps.13080","article-title":"Repetitive enhancement of serum BDNF subsequent to continuation ECT","volume":"140","author":"Vanicek","year":"2019","journal-title":"Acta. Psychiatr. Scand"},{"issue":"2","key":"10.1016\/j.euroneuro.2024.06.008_bib0122","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcad046","article-title":"Brain-derived neurotrophic factor released from blood platelets prevents dendritic atrophy of lesioned adult central nervous system neurons","volume":"5","author":"Want","year":"2023","journal-title":"Brain Commun"},{"issue":"1","key":"10.1016\/j.euroneuro.2024.06.008_bib0123","doi-asserted-by":"crossref","first-page":"20232","DOI":"10.1038\/s41598-020-77046-6","article-title":"Factors affecting stability of plasma brain-derived neurotrophic factor","volume":"10","author":"Wessels","year":"2020","journal-title":"Sci. Rep"},{"issue":"7","key":"10.1016\/j.euroneuro.2024.06.008_bib0124","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/j.pnpbp.2011.06.013","article-title":"Serum BDNF levels before treatment predict SSRI response in depression","volume":"35","author":"Wolkowitz","year":"2011","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"7","key":"10.1016\/j.euroneuro.2024.06.008_bib0125","doi-asserted-by":"crossref","first-page":"665","DOI":"10.2174\/1570159X14666151208113006","article-title":"Stress, the autonomic nervous system, and the immune-kynurenine pathway in the etiology of depression","volume":"14","author":"Won","year":"2016","journal-title":"Curr. Neuropharmacol"},{"issue":"11","key":"10.1016\/j.euroneuro.2024.06.008_bib0126","doi-asserted-by":"crossref","first-page":"3469","DOI":"10.1523\/JNEUROSCI.10-11-03469.1990","article-title":"Human platelets contain brain-derived neurotrophic factor","volume":"10","author":"Yamamoto","year":"1990","journal-title":"J. Neurosci. Off. J. Soc. Neurosci"},{"issue":"1","key":"10.1016\/j.euroneuro.2024.06.008_bib0127","first-page":"4","article-title":"Molecular and cellular mechanisms underlying the antidepressant effects of ketamine enantiomers and its metabolites","volume":"9","author":"Yang","year":"2019","journal-title":"Transl. Psych."},{"issue":"1","key":"10.1016\/j.euroneuro.2024.06.008_bib0128","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s44192-022-00012-3","article-title":"Ketamine treatment for depression: a review","volume":"2","author":"Yavi","year":"2022","journal-title":"Discov. Ment. Heal"},{"issue":"4","key":"10.1016\/j.euroneuro.2024.06.008_bib0129","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.pnpbp.2011.02.009","article-title":"The brain-derived neurotrophic factor (BDNF) polymorphism Val66Met is associated with neither serum BDNF level nor response to selective serotonin reuptake inhibitors in depressed Japanese patients","volume":"35","author":"Yoshimura","year":"2011","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"5","key":"10.1016\/j.euroneuro.2024.06.008_bib0130","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.pnpbp.2007.03.001","article-title":"Effects of paroxetine or milnacipran on serum brain-derived neurotrophic factor in depressed patients","volume":"31","author":"Yoshimura","year":"2007","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"6","key":"10.1016\/j.euroneuro.2024.06.008_bib0131","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1093\/ijnp\/pyy008","article-title":"Association of BDNF Val66Met polymorphism and brain BDNF levels with major depression and suicide","volume":"21","author":"Youssef","year":"2018","journal-title":"Int. J. Neuropsychopharmacol"},{"issue":"2","key":"10.1016\/j.euroneuro.2024.06.008_bib0132","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.20m13699","article-title":"The prevalence and national burden of treatment-resistant depression and major depressive disorder in the united states","volume":"82","author":"Zhdanava","year":"2021","journal-title":"J. Clin. Psychiatry"},{"issue":"9","key":"10.1016\/j.euroneuro.2024.06.008_bib0133","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/j.neurobiolaging.2006.06.011","article-title":"Serum neurotrophins\u2013a study on the time course and influencing factors in a large old age sample","volume":"28","author":"Ziegenhorn","year":"2007","journal-title":"Neurobiol. Aging"},{"issue":"1\u20132","key":"10.1016\/j.euroneuro.2024.06.008_bib0134","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jns.2005.03.010","article-title":"Secretion of brain-derived neurotrophic factor by glatiramer acetate-reactive T-helper cell lines: implications for multiple sclerosis therapy","volume":"233","author":"Ziemssen","year":"2005","journal-title":"J. Neurol. Sci"},{"issue":"1","key":"10.1016\/j.euroneuro.2024.06.008_bib0135","doi-asserted-by":"crossref","DOI":"10.1038\/s41398-019-0491-9","article-title":"Brain-derived neurotrophic factor as a possible predictor of electroconvulsive therapy outcome","volume":"9","author":"van Zutphen","year":"2019","journal-title":"Transl. Psychiatry"}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X24001524?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X24001524?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,7]],"date-time":"2024-09-07T22:41:27Z","timestamp":1725748887000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X24001524"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":138,"alternative-id":["S0924977X24001524"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2024.06.008","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of antidepressant treatment on blood BDNF levels in depressed patients: A review and methodological recommendations for assessment of BDNF in blood","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2024.06.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}